Bart Van Rhijn

Chief Financial and Business Officer at Nanobiotix, Executive Board Member

Cambridge, Massachusetts, United States

About

Highly adaptable, public company CFBO with 25+ years of progressive leadership & operational experience in Business, Finance, BD&L, Tax & Legal in NA & Europe. Biotech focused with prior experience in Life Sciences & Technology at public & private companies, development stage and commercial. Unlocks value via portfolio management, business partnering & performance improvement. Establishes strong rapport across all layers & gains trust through building high-performing, diverse teams. Drives long-term value & optimizes cash flow. Board Experience (Investment and venture fund, start-up companies). Servant Leader, Builds Trust, Strategic Business Partner, Communicator, Cross-cultural Experience, BD, Licensing, M&A, Integration, Dual Listing Experience, Investor Relations, Banking Syndicate Creation, Fundraising, SOX Implementation, Enterprise Risk Management, Compliance, Debt Restructuring & Cash Flow Optimization, Strategic Planning, Lifecycle Management, Performance Management, Dashboarding, Turnaround & Restructuring, Automation Roadmap, ERP Implementation

Experience

  • Chief Financial and Business Officer at Nanobiotix
    Jun 2021 - Present · 5 yrs 1 mo

  • Member Board of Directors at M3SC Fund
    Jul 2023 - Present · 3 yrs

  • Venture Partner at 1414 Ventures
    Nov 2020 - Present · 5 yrs 8 mos

    A Digital Identity focused Venture Fund

  • Advisory Board Member at BlocHealth
    Apr 2019 - May 2022 · 3 yrs 2 mos

    Sold to SteadyMD

  • CFO at Servier Pharmaceuticals
    Sep 2018 - Jun 2021 · 2 yrs 10 mos